T he need for payment reform with rehabilitation providers is evident. A system that reimburses providers based only on the amount of time they spend, regardless of the effectiveness of the treatment, incentivizes providers to do more without necessarily providing value to patients.
As part of the Middle Class Tax Relief Act of 2012, 1,2 the Centers for Medicare and Medicaid Services (CMS) required rehabilitation providers, including physical therapists, to report functional data on all patients receiving outpatient treatment. The intent was to use this information to "meet the statutory requirement," "gather data," "and analyze potential alternative payment systems" for outpatient therapy services. 3 Following a 6-month test period beginning January 1, 2013, all claims submitted after July 1 required these codes for payment. Under this new rule, providers submit nonpayable G-Codes, placing the patient in a functional category. The categories were selected by CMS from the International Classification of Functioning, Disability and Health (ICF) in 4 specific areas: (1) mobility, (2) changing and maintaining body position, (3) carrying moving and handling objects, and (4) self-care. In addition, 2 "other" G-Codes define functional limitations when one of the more specific categorical codes does not apply.
For each G-Code, a modifier would be required to report the severity/complexity for that functional limitation. The therapist selects 1 of 7 functional limitation modifier codes reflecting the beneficiary's functional impairment. One code represents the patient being 0% impaired (CH) and another 100% impaired (CN). In between these 2 extremes, the levels of impairment are split into five 20% "levels" (CI through CM). Therapists are required to identify current status and discharge goal status for functional reporting on the initial visit, current status on the 10th visit, and at discharge. Because a high number of patients discontinue therapy without alerting their therapist, CMS added, "We…require discharge reporting (except in cases where therapy services are discontinued by the beneficiary prior to the planned discharge visit." 3 Along with their clinical judgment, CMS recommends therapists use functional assessment tools to help determine the patient's functional limitation. CMS recommends but does not require or restrict therapists in the selection of these tools. The Activity Measure for Post-Acute Care (AM-PAC) has been recommended by CMS. 4 It can be applied to multiple clinical conditions in the postacute setting, including outpatient orthopedics, which is the largest group of patients seen in the outpatient setting by physical therapists.
However, Jette et al 5 determined that the CMS functional limitation severity modifier system may not be valid to identify improvement in function and could yield inaccurate results depending on the patients' initial AM-PAC score.
The American Physical Therapy Association has recommended patientreported outcomes (PROs) for use with orthopedic patients. 6 Therapists may also utilize additional data, including the patient's pain, comorbidities, cognition, age, and prognosis combined with the therapist's judgment to determine functional impairment levels. 1 CMS has not standardized a process for determining functional reporting but is "hopeful" that those using measurement tools will modify them "so the results match the Medicare severity/ complexity scale or issue instructions or guidance on translating the results to the Medicare severity/complexity scale." Without a standardized process for therapists to determine the level of functional limitation, it is impossible to accurately compare data across providers or to make equitable payments. To make the CMS functional limitation data meaningful, therapists would need to use a standardized process for determining functional limitations, place the patient accurately in the 7-level severity/complexity scale, measure the patient's change, and have that change correlate with changes in 7-level scale. Currently, there is wide variation in how the severity/complexity scale modifier code is determined by clinicians. The required 7-level scale based on 20% levels appears to lack clinical relevance because its responsiveness to change has not been demonstrated. 5 For example, when using the Modified Low Back Pain Disability Questionnaire to evaluate a patient's change in function, the patient could improve 3 times the minimal clinically important difference (MCID) (18% points) and not change within the severity/complexity scale (20% points). It is also unclear how CMS will use functional limitation data 1 to determine payment alternatives. 7 The purpose of this study was to compare the responsiveness to change on the 7-level severity/complexity modifier code scale as originally proposed by CMS to a derived scale implemented by Intermountain Healthcare in the Rehabilitation Outcomes Management System (ROMS). Comparisons were made using actual patient scores on 5 condition-specific PROs.
Methods

Data Sources
This study examined 165,183 patient records that had initial and final patient-reported outcome scores from January 1, 2000, to June 30, 2013 , and compared these scores to 46,334 patient records gathered from July 1, 2013, to December 31, 2015. The patient-reported measures included the Modified Low Back Pain Disability Questionnaire, Neck Disability Index (NDI), Disability of the Arm, Shoulder, Hand (DASH), Lower Extremity Function Scale (LEFS), and Knee Outcome Scale (KOS). At Intermountain, PROs are collected at every visit on 94.5% of all patients. 8 Intermountain Healthcare's Institutional Review Board waived oversight of this study because it did not meet the definition of human subjects research.
The Modified Low Back Pain Disability Questionnaire was used to assess disability related to low back pain (LBP). This modified version replaces the sex life item with an employment/homemaking item and has been found to be reliable, valid, and sensitive to change. 9 It is a 10-item scale, and each item is scored from 0 to 5, related to LBP daily activities. The total scored is summed and expressed as a percentage of disability. Higher scores indicate greater disability, and the MCID has been estimated at 6 points. 9 The NDI was used for the patientreported outcome measure for patients with neck pain. It is the most commonly used region-specific scale for patients with neck pain 10 and has been demonstrated to be a reliable and valid outcome measure. [11] [12] [13] [14] It is composed of 10 items related to neck pain and patient's tolerance for daily activities, and each item is scored from 0 to 5; the scores are summed and expressed as a percentage. Higher scores indicate greater disability. The NDI has been shown to be responsive to detect clinical change. Only a few studies have reported MCID, and the more common estimate is 10%. 15 The DASH is a 30-item, self-report questionnaire designed to measure physical function and symptoms in patients with any or several musculoskeletal disorders of the upper limb. The questionnaire was designed to help describe the disability experienced by people with upper-limb disorders and also to monitor changes in symptoms and function over time. Higher scores indicate greater disability. 16 The DASH has been shown to have good validity, reliability, and responsiveness to change. 17 At least 27 of the 30 items must be completed for a score to be calculated. Each item is scored out of 5. The assigned values for all completed responses are summed and averaged. This value is then transformed to a score out of 100 by subtracting 1 and multiplying by 25. 16 The LEFS is a patient self-reported measure to assess disability for orthopedic conditions of the lower extremity. The LEFS was used for all lower extremity conditions other than the knee (ie, hip, foot, and ankle). The LEFS has 20 items, each item is scored from 0 to 4, the items are summed, and the total score ranges from 0 to 80, with higher scores indicating better functional ability. The MCID for the LEFS is estimated to be 9 points. This measure has been shown to be valid, reliable, sensitive, and responsive to detecting clinical change in patients. 18, 19 The KOS was used for patients with limitations due to painful knee conditions. It consists of 14 items with a total score expressed on a scale of 0 to 100 points. Each item is scored from 0 to 5. The scores of each item are summed, divided by 70, and multiplied by 100 to provide an overall KOS percentage rating. Higher scores represent higher functional ability. 20 The KOS is a reliable, valid, and responsive measure for assessment of patients' functional limitations due to a wide variety of disorders and impairments of the knee. 18, [20] [21] [22] The MCID level has been estimated for patella-femoral dysfunction at 7.2 points 23 and demonstrates a range of 7.2-10.5 points in patients with knee osteoarthritis, depending on elapsed time to follow-up measurement. 22 An 11-point numeric pain rating scale (0 = no pain to 10 = worst imaginable pain) was used to assess current pain intensity. Although there is some variation in the literature, the MCID on the numeric pain scale has been estimated at or slightly less than 2 points of change for patients with various musculoskeletal conditions. [23] [24] [25] MCIDs have been determined for each scale. The condition-specific PROs analyzed in this study include the Modified Low Back Pain Disability Questionnaire for patients with low back pain with an MCID of 6 points, 9 the Neck Disability Index (NDI) 26, 27 for patients with neck pain with an MCID of 10 points, 25 the DASH for patients with upper extremity pain 16 with an MCID of 10 points, 28 the Knee Outcome Survey (KOS) 20 with an MCID of 10 points 25 for patients with knee pain, and the Lower Extremity Functional Scale 18 (LEFS) for patients with lower extremity pain with an MCID of 9 points. 19 All of these PROs have been validated in the literature and can be converted to a 0% to 100% scale. The LEFS is reported using the original 0-to 80-point scale based on the raw scores. These tools are without limitations, including floor and ceiling effects, especially when applying them to the elderly population.
Data Synthesis and Analysis
The initial and final scores of the PROs were combined into 1 large data set. The raw score values for each PRO that divided these scores into 7 levels were then found, with the 2 extreme levels (CH and CN) containing approximately 3% of the scores each, the next 2 most extreme levels (CI and CM) containing 17% each, and the remaining 3 middle levels (CJ, CK, and CL) containing 20% of the scores each. The functional limitation levels proposed by CMS identified the 2 extreme levels at 0% and 100% impairment and the 5 interior levels to represent 20% increments of impairment. The study started with the same idea as the CMS score of having five 20% levels representing the middle of the data, with the 2 extreme levels (CN and CH) representing the ends of the scale. The first change was to have the actual 20% interval on the ROMS scale based on the number of observed raw scores that represents 20% of the population. This is in contrast to the CMS scale that uses 20% of the potential range of the outcome measure score. For example, with the Modified Low Back Pain Disability Questionnaire, 20% of admit and discharge scores were between 14 and 25, so this raw score range was used to define the CJ interval. Then discussion took place regarding what is meant by "fully disabled," and the conclusion was that any score greater than 65-70 would be considered fully disabled, 29 which corresponded to about 3% of the observed scores in the data set. Based on this, the decision was to increase CN and CH to represent 3% of values and reduce CM and CI to 17% (keeping CL, CK, and CJ at 20%). This same procedure was applied to each measure (Tab. 1).
The analysis accomplishes 2 important distinctions when comparing ROMS to CMS scales. It defines the severity levels on the basis of raw score ranges and distributes the population more equitably on the basis of real observed scores. Each severity modifier level is narrower and therefore more sensitive to a patient's change score. instead of requiring a 20-point improvement to achieve 1 level of improvement on the 7-level scale, only an improvement of 11 points would be needed, at most, to effect a change in the severity/complexity level within the 3 middle levels.
Often, clinicians with or without the help of online tools will take the PRO score and transpose it directly to the functional limitation levels proposed by CMS, which are in 20% increments in the 5 interior levels of impairment. 30 This article refers to this transposition simply as a "straight across transposition" in our observations.
The sensitivity and specificity of the 2 models, Intermountain ROMS and straight across transposition, were compared to the CMS severity/complexity modifier levels (Tab. 2). The analysis used the change scores on the PROs by calculating the sensitivity (true positive rate) and the specificity (true negative rate) to compare responsiveness of the ROMS and CMS severity/complexity modifier scale levels on the basis of whether an MCID was associated with an appropriate change in the scale. The MCIDs for each PRO are listed in Table 1 , and the MCID for each specific PRO was used in the analysis. For example, the MCID for the Modified Low Back Pain Disability Questionnaire was 6 points. 9 Table 2 shows the probability of correctly identifying the patients who "improved" an MCID level and appropriately changed a severity/complexity modifier level. It is interpreted as the probability of correctly identifying improved patients who achieved an MCID and changed their severity/complexity reporting level.
Results
Patient characteristics and scores related to each PRO for the 2 time frames before and after July 1, 2013, are provided in Table 3 .
The narrower intervals used in ROMS reflect more accurately the skewed distribution of the actual data (Fig. 1) .
The histogram in Figure 1 shows the distribution of the Modified Low Back Pain Disability Questionnaire scores at admission for 11,718 patients. The boxes above the histogram represent the number of patients categorized into each level using the models for the ROMS and the straight across transposition of the CMS severity/complexity modifier levels based on the actual This basic approach places relatively few patient scores into the CMS 7-level scale at the extremes (CL, CM, CN) where not very many scores were observed, and places the majority of admit scores into levels CJ and CK. In contrast, the Intermountain ROMS system uses narrower intervals where the frequency of the actual scores is more highly concentrated, and wider intervals in the region where only relatively few observed scores fell. The narrower range of scores for each level affords a better chance of a patient being identified as having achieved a change in the severity/complexity scale if their outcome difference score is equal to the MCID. The clinical importance of more narrow modifier levels using the ROMS scale represents an increased probability that if a patient achieves a difference score greater than or equal to the MCID, then the patient is more likely to improve to a modifier level that represents the patient's functional improvement, and vice versa if the patient were to worsen.
The responsiveness of the ROMS and CMS scales is depicted graphically as a ribbon plot in Figure 2 . Notice the preponderance of downward-sloping lines from admit score to discharge score to a PRE = all patients in the data set from July 1, 2000, to July 1, 2013; POST = all patients in the data set admitted after July 1, 2013 (until December 31, 2015); DASH = Disability of the Arm, Shoulder, Hand; KNEE = Knee Outcome Scale-Activities of Daily Living; LEFS = Lower Extremity Function Scale; MLBPDQ = Modified Low Back Pain Disability Questionnaire; NDI = Neck Disability Index.
depict improvement, thus the change to an improved level of severity/ complexity. In contrast, the horizontally oriented bands depict no change in scale level. The thickness of the band represents the frequency of patients at a particular admit level and the discharge level. Taking the 2 concepts together, the figure represents the direction of change between levels and the proportion of patients making those changes.
The online supplement provides ribbon plots related to each of the other PRO instruments (DASH, NDI, LEFS, KOS) (eFigs. 2a-2d, available at https:// academic.oup.com/ptj).
The Intermountain ROMS severity/complexity scale levels for the Modified Low Back Pain Disability Questionnaire identified 87.9% of patients as "improved" when they had achieved an MCID (sensitivity), and 90.8% as "not improved" when they truly had not achieved an MCID (specificity). In contrast, using a straight across transposition of PRO scores to the CMS severity/complexity scale levels depicted 74.2% sensitivity and 94.3% specificity. Using ROMS, the "gain" in sensitivity is 13.7% compared to using a straight across transposition to the CMS scale, whereas ROMS has only a 3.8% "loss" in specificity. Table 2 lists the sensitivity and specificity values for the 5 PROs. Each value represents the probability of correctly identifying improved patients who achieved an MCID on the PRO and correctly changed their severity/complexity reporting level.
Discussion
The responsiveness to change for reporting of severity/complexity modifiers of a straight across transposition was compared to a derived scale used by Intermountain Healthcare physical therapists. Our concern was that the 20% CMS levels were too large to depict whether "true" change had occurred on the basis of PROs. Using the straight across transposition of the CMS scale for the Modified Low Back Pain Disability Questionnaire, the single category CN (100% impaired) captured 2 patients of the total population of 165,183 patients (Fig. 1) .
The single category CN on ROMS accounted for 617 scores observed in the right tail of the histogram. Modified Low Back Pain Disability Questionnaire scores greater than 60% were considered as completely impaired. The straight across transposition used all of 2 categories and most of a third to account for 3% of the population with scores of 60% to 100% on the Modified Low Back Pain Disability Questionnaire. This leaves only 4 levels to represent the majority of the population, and only 2 of the 4 remaining levels represent the majority of observed scores (CJ and CK). In comparison, ROMS utilizes 4 levels in the ranges of Modified Low Back Pain Disability Questionnaire scores that occur most frequently as observed on the histogram: CJ (14-25), CK (26) (27) (28) (29) (30) (31) (32) (33) (34) (35) , CL (36-47), and CM (48-65). Two remaining levels capture the higher-functioning patients (CH and CI). ROMS complexity/ modifier levels are based on observed scores. This is a wholly different concept from cross-walking the PRO score to the 7-level straight across transposition scale on the basis of 20-percentage-point ranges. 30 The latter approach of using 20% intervals to define levels does not account for how few patients are actually represented in the tails of the distribution of scores and how unlikely it is that patients can change levels that are 20% points wide, even when a meaningful clinical change has occurred. The transposition of a 0% to 100% survey score to the 20% levels of the straight across transposition 7-level scale is used commonly and is not sensitive to change in clinical practice. 30 Similar to the observations described above for the Modified Low Back Pain Disability Questionnaire, a similar pattern is noticed for each of the other PROs. The CMS scale includes a relatively small number of patients in the right tail (CN-100% impaired), and only 2 of the 4 remaining levels represent the majority of observed scores (CJ and CK), whereas in the ROMS scale, a greater proportion of patients are captured in the right tail (CN). The straight across transposition of the CMS scale uses all of 2 categories and some of a third category to capture this 3% of the populations of each PRO. In addition, what CMS represents in 2 of the most populated levels (CJ and CK), ROMS captures and partitions these patient scores into 4 levels by creating narrower complexity/severity levels. As a result, the ROMS scale increases the sensitivity values for each PRO, so it is more likely that if a patient achieves an MCID, the K-modifier category will also improve and represent an objective measure of improvement.
The analytical approach that was used above could very well be applied to PROs such as the AM-PAC that are not diagnostic specific. The analysis would require a data set with a large population of scores of the not-diagnostic-specific PROs to identify the actual 20% interval based on raw scores that would represent 20% of the population. The raw score ranges could then be applied to represent a meaningful distribution of the population to fit the 7-level scale used by CMS. Depending on the specific PRO and analysis of the population data, the percentages may differ from our analysis (3%, 17%, 20%, 20%, 20%, 17%, 3%). Conceptually, a not-diagnostic-specific PRO data set analysis may produce different divisions of the population, but the rationale to use the raw scores to define the range of a given level is essentially similar and in contrast to the CMS scale that relies on 20% of the potential range of the outcome measure score itself.
In the sensitivity/specificity analysis (Tab. 2) using the Modified Low Back Pain Disability Questionnaire data as an example, a greater level of sensitivity is achieved using ROMS compared to the straight across transposition CMS scale. ROMS identifies a greater proportion of patients, "almost always," who achieve an MCID improvement and improve a complexity/modifier level (87.9% true positives). The ROMS level of specificity (true negatives) also remained high at 90.8%. 31 In contrast, the straight across transposition CMS scale has a lower sensitivity (74.2%), meaning it had identified 13.4% fewer patients who had truly changed, and only a slightly higher specificity (93.4%). For each of the other 4 PROs, the sensitivity using the ROMS scale was greater than 95% and all were higher than the sensitivities using the CMS scale. In fact, the smallest improvement in sensitivity using ROMS was about 5 percentage points for the KOS (Tab. 2).
If reimbursement was determined by changes in the CMS 7-level modifier scale, then a greater percentage of patients who made a clinically meaningful improvement would not qualify for reimbursement. Using the ROMS scale, a greater proportion of patients are identified as achieving clinical improvement with greater than 90% accuracy. We believe this represents a stronger justification compared to using a straight across transposition to the CMS scale of PRO scores to a 7-level scale of 20% increments. The ROMS scale would lead to more appropriate reimbursement.
Limitations of the study include the lack of geographic representation for the United States. We were also unable to compare the PRO to a patient's perceived global rating of change (GROC), which would have provided a reference standard to gauge the validation of improvement.
Conclusion
The Intermountain ROMS scale provides a standard approach to identify the Medicare complexity/severity modifiers and to detect improvement when patients achieve meaningful clinical improvement. The ROMS scale has greater sensitivity and is highly accurate compared with a straight across transposition of patient-reported outcome scores. 
